To date, anti-CD47 treatment has been already shown to elicit a positive effect on intratumoral NK cell activity, and furthermore, a study by Kim et al. suggests that blocking of CD47 activates NK cell-mediated lysis of head and neck squamous cell carcinoma cell lines [15, 47]. Here, CD47 is linked to head and neck squamous cell carcinoma.